GSK-A1 is a potent and selective PI4KA inhibitor that suppresses calcium-induced prolactin secretion without impacting calcium signaling or Prl gene expression. Its inhibition of the host PI4KA enzyme also confers promising anti-HCV activity, making it a valuable tool for studying phosphatidylinositol signaling and viral replication in vitro.
Molekulargewicht:
574.63
Reinheit:
98.97% (May vary between batches)
CAS Nummer:
[1416334-69-4]
Formel:
C29H27FN6O4S
Target-Kategorie:
PI4K,HCV Protease
Anwendungsbeschreibung:
Solubility: DMSO:2.3 mg/mL (4 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten